Covalon Technologies (OTCMKTS:CVALF) Releases Earnings Results, Beats Estimates By $0.02 EPS

Posted by Francis Steltz on May 21st, 2026

Covalon Technologies (OTCMKTS:CVALF – Get Free Report) issued its quarterly earnings results on Thursday. The company reported $0.03 EPS for the quarter, topping analysts’ consensus estimates of $0.01 by $0.02, Zacks reports. Covalon Technologies had a return on equity of 3.31% and a net margin of 3.08%.

Covalon Technologies Stock Performance

Shares of OTCMKTS CVALF opened at $1.49 on Thursday. Covalon Technologies has a 52 week low of $1.16 and a 52 week high of $2.14. The stock has a market capitalization of $41.15 million, a P/E ratio of 74.54 and a beta of 0.59. The stock’s fifty day moving average is $1.37 and its 200 day moving average is $1.33.

About Covalon Technologies

(Get Free Report)

Covalon Technologies Ltd. (OTCMKTS:CVALF) is a Canadian medical device and life sciences company specializing in advanced wound care and infection prevention solutions. Based in Toronto, Ontario, Covalon leverages proprietary photochemical bonding technology to create antimicrobial and anti-adhesion polymer coatings for a range of medical devices and wound dressings. The company’s core focus is on reducing surgical site infections and improving healing outcomes through innovative biomaterials.

The company’s product portfolio comprises hydrogel-based wound dressings and polymer-coated medical device components.